# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-18-324949
Filing Date
2018-11-13
Accepted
2018-11-13 08:46:05
Documents
31
Period of Report
2018-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d644048d8k.htm | 8-K | 20315
2 | EX-99.1 | d644048dex991.htm | EX-99.1 | 29305
3 | GRAPHIC | g644048ex99_1s10g1.jpg | GRAPHIC | 259907
4 | GRAPHIC | g644048ex99_1s11g1.jpg | GRAPHIC | 247926
5 | GRAPHIC | g644048ex99_1s12g1.jpg | GRAPHIC | 298130
6 | GRAPHIC | g644048ex99_1s13g1.jpg | GRAPHIC | 227613
7 | GRAPHIC | g644048ex99_1s14g1.jpg | GRAPHIC | 285700
8 | GRAPHIC | g644048ex99_1s15g1.jpg | GRAPHIC | 262220
9 | GRAPHIC | g644048ex99_1s16g1.jpg | GRAPHIC | 221269
10 | GRAPHIC | g644048ex99_1s17g1.jpg | GRAPHIC | 381184
11 | GRAPHIC | g644048ex99_1s18g1.jpg | GRAPHIC | 245908
12 | GRAPHIC | g644048ex99_1s19g1.jpg | GRAPHIC | 237315
13 | GRAPHIC | g644048ex99_1s1g1.jpg | GRAPHIC | 203642
14 | GRAPHIC | g644048ex99_1s20g1.jpg | GRAPHIC | 303099
15 | GRAPHIC | g644048ex99_1s21g1.jpg | GRAPHIC | 208201
16 | GRAPHIC | g644048ex99_1s22g1.jpg | GRAPHIC | 364650
17 | GRAPHIC | g644048ex99_1s23g1.jpg | GRAPHIC | 236299
18 | GRAPHIC | g644048ex99_1s24g1.jpg | GRAPHIC | 213733
19 | GRAPHIC | g644048ex99_1s25g1.jpg | GRAPHIC | 295510
20 | GRAPHIC | g644048ex99_1s26g1.jpg | GRAPHIC | 328978
21 | GRAPHIC | g644048ex99_1s27g1.jpg | GRAPHIC | 217665
22 | GRAPHIC | g644048ex99_1s28g1.jpg | GRAPHIC | 247763
23 | GRAPHIC | g644048ex99_1s29g1.jpg | GRAPHIC | 237073
24 | GRAPHIC | g644048ex99_1s2g1.jpg | GRAPHIC | 402324
25 | GRAPHIC | g644048ex99_1s3g1.jpg | GRAPHIC | 299076
26 | GRAPHIC | g644048ex99_1s4g1.jpg | GRAPHIC | 314603
27 | GRAPHIC | g644048ex99_1s5g1.jpg | GRAPHIC | 192324
28 | GRAPHIC | g644048ex99_1s6g1.jpg | GRAPHIC | 240025
29 | GRAPHIC | g644048ex99_1s7g1.jpg | GRAPHIC | 349885
30 | GRAPHIC | g644048ex99_1s8g1.jpg | GRAPHIC | 257748
31 | GRAPHIC | g644048ex99_1s9g1.jpg | GRAPHIC | 184144
| Complete submission text file | 0001193125-18-324949.txt |  | 10748126

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 181175415
SIC: 2834 Pharmaceutical Preparations